Continuing Access to Harvard Longitudinal Survey Data
Closed Special Notice Posted
- Solicitation number
- FDA_7222026
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Responses due
- Set-aside
- 8(a) Sole Source
Opportunity facts
- Place of performance
- Rockville, Maryland 20852, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Food and Drug Administration is conducting a sole-source 8(a) procurement to acquire continuing access to longitudinal survey data from Harvard College/Harvard School of Public Health prospective cohort studies, with a capability statement response deadline of August 7, 2026 at 3:00 PM EST.
The FDA Human Foods Program seeks to obtain and analyze data from five ongoing Harvard studies—the Nurses' Health Study (approximately 122,000 participants since 1976), Nurses' Health Study II (approximately 116,000 participants since 1989), Health Professionals Follow-Up Study (approximately 100,000 men since 1986), Growing Up Today Study (16,882 children since 1996), and Growing Up Today Study 2 (10,923 children since 2004)—to advance understanding of relationships between dietary intake, supplement use, and other exposures related to FDA-regulated products and health outcomes across the lifespan and across generations. Research priorities include characterization of novel dietary supplements and cannabis products, dietary intake patterns and health effects related to hazardous exposures, maternal exposures and pregnancy outcomes, and intergenerational health effects. The base period of performance runs from September 30, 2026 to September 29, 2027 with one option year through September 29, 2028. Deliverables include a project plan within 14 business days of award, monthly progress reports, questionnaire data extractions within 60–90 business days, specialized analytic support within 4–7 months, and co-authored summaries and publications within 8–12 months. Work is performed at the contractor's site with no travel required. Organizations believing they can meet stated requirements may submit written capability statements to Samad Sahil, Contract Specialist, at samad.sahil@fda.hhs.gov. The government reserves the right to compete the contract based on responses received.
Notice text
Cross-sectional data sets, such as derived from the National Health and Nutritional Examination Survey (NHANES), are readily available at no cost over the web, and analyses of such data sets can help suggest potential associations between dietary intake exposures and health outcomes. However, because cross- sectional surveys collect exposure and outcome data at the very same point in time, they cannot help us understand if exposures through routine dietary intake and other exposures related to regulated products preceded diagnosis of adverse health conditions.
Longitudinal data – often collected repeatedly from participants in prospective cohort studies conducted over several years – help to reveal relationships between dietary and environmental exposures and the development of health conditions over time. The FDA Human Foods Program (HFP)/Office of Surveillance Strategy and Risk Prioritization (OSSRP)/Division of Evaluation and Population Health Science (DEPHS)/Epidemiology and Medical Sciences Branch (EMSB) is interested in obtaining such longitudinal data from the ongoing President and Fellows of Harvard College/Harvard School of Public Health (HSPH) longitudinal studies:
- Nurses’ Health Study original cohort (NHS: ~122,000 participants, since 1976)
- Nurses’ Health Study II (NHSII: ~116,000 participants, began in 1989)
- Health Professionals Follow-Up Study (HPFS: ~100,000 men, since 1986)
- Growing Up Today Study (GUTS: children of NHS participants, including 16,882 girls and boys; since 1996)
- Growing Up Today Study 2 (GUTS2: children of NHSII participants, including 10,923 girls and boys; since 2004)
Analyses of longitudinal data from these studies will help monitor diet and lifestyle risk factors, allow for scientific evaluation of potential causal links between these factors and chronic disease incidence, and enhance understanding of individual and intergenerational relationships between dietary intake, lifestyle exposures, and chronic conditions/long-term health effects throughout the lifespan, among parents and offspring, including evaluating grandmother-maternal-child outcomes. This information will help the FDA improve dietary policy and consumer education to protect and promote public health.
Please see attched SOW.
Files
| File | Type | Posted |
|---|---|---|
| INTENT TO SOLE SOURCE.pdf | ||
| Scope of Work.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Comprehensive Data Management & Streamlining Solution for Business-Critical Data (Data Stream) | Food and Drug Administration | Woman-Owned Small Business |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity